Shufro Rose & Co’s Salarius Pharmaceuticals SLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-5
Closed -$7K 340
2022
Q1
$7K Buy
+5
New +$7K ﹤0.01% 333